Need extra support quickly? We are working with clients around the world right now to help them tackle new challenges from COVID-19.  

How can we help you? Learn More >

Patrick Donnelly

Board Member

Mr. Donnelly, who has more than 35 years of experience, was most recently Chairman and Chief Executive Officer of Aptiv Solutions, a global pharmaceutical development services business he founded which sold to ICON (NASDAQ:ICLR) in May 2014. Prior to this, Pat served as President, Chief Executive Officer, and was one of the founders of PRA International (now PRA Health Sciences, NASDAQ:PRAH). He was instrumental in building PRA over twelve years from a small regional contract research organization to a global leader in the industry. Mr. Donnelly received his M.B.A. from Pennsylvania State University in 1984 and received his BS from the University of Missouri in 1980.

Pat currently serves as a board director for Linden portfolio companies, ProPharma Group, and Advarra.  Pat is also a board director at MedGenesis Therapeutix, Phase 5 LLC, and Rediscovery Life Sciences.

Company Blog

March 25, 2020
Health Authorities’ Information on the COVID-19 Pandemic Throughout Europe, Part…
How is COVID-19 affecting clinical trials across Europe? Hanneke Dominicus provides more information on… Read More
March 23, 2020
Health Authorities’ Information on the COVID-19 Pandemic Throughout Europe, Part…
How is COVID-19 affecting EU health authorities? Learn more about the recommendations and measures… Read More
March 12, 2020
Embracing Risk Management Principles: As Easy as One, Two, Three
Risk management may seem like a complex concept, but is something you probably assess… Read More
More Articles

UPCOMING Events

All Events
Contact Us